These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6883963)

  • 1. Chloramphenicol and chloramphenicol succinate concentrations in patients with renal impairment.
    Brasfield JH; Record KE; Griffen WO; Mattingly S
    Clin Pharm; 1983; 2(4):355-8. PubMed ID: 6883963
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloramphenicol sodium succinate kinetics in critically ill patients.
    Slaughter RL; Pieper JA; Cerra B; Brodsky B; Koup JR
    Clin Pharmacol Ther; 1980 Jul; 28(1):69-77. PubMed ID: 7389257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability and clearance of chloramphenicol after intravenous chloramphenicol succinate.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1981 Sep; 30(3):368-72. PubMed ID: 7273601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and urine concentrations of acebutolol and its acetyl metabolite in patients with renal functional impairment.
    Munn S; Bailey RR; Begg E; Ebert R; Ferry DG
    N Z Med J; 1980 Apr; 91(658):289-91. PubMed ID: 6930006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloramphenicol serum concentration falls during chloramphenicol succinate dosing.
    Nahata MC; Powell DA
    Clin Pharmacol Ther; 1983 Mar; 33(3):308-13. PubMed ID: 6825386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high performance liquid chromatographic measurement of chloramphenicol and its succinate esters in serum.
    Soldin SJ; Golas C; Rajchgot P; Prober CG; MacLeod SM
    Clin Biochem; 1983 Jun; 16(3):171-7. PubMed ID: 6851080
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetics of chloramphenicol succinate in parenteral administration].
    Havelka J; Mertenová J; Procházka J
    Cas Lek Cesk; 1968 Oct; 107(42):1268-72. PubMed ID: 5681916
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloramphenicol succinate pharmacokinetics in Macaca nemestrina: dose dependency study.
    Koup JR; Weber A; Smith AL
    J Pharmacol Exp Ther; 1981 Nov; 219(2):316-20. PubMed ID: 7288623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloramphenicol hemodialysis clearance.
    Blouin RA; Erwin WG; Dutro MP; Bustrack JA; Rowse KL
    Ther Drug Monit; 1980; 2(4):351-4. PubMed ID: 7222188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of chloramphenicol and chloramphenicol succinate in plasma using high-performance liquid chromatography.
    Velagapudi R; Smith RV; Ludden TM; Sagraves R
    J Chromatogr; 1982 Mar; 228():423-8. PubMed ID: 7076772
    [No Abstract]   [Full Text] [Related]  

  • 12. Simultaneous measurement of chloramphenicol and chloramphenicol succinate by high-performance liquid chromatography.
    Aravind MK; Miceli JN; Kauffman RE; Strebel LE; Done AK
    J Chromatogr; 1980 Nov; 221(1):176-81. PubMed ID: 7451621
    [No Abstract]   [Full Text] [Related]  

  • 13. High-pressure liquid chromatographic assay for chloramphenicol, chloramphenicol-3-monosuccinate, and chloramphenicol-1-monosuccinate.
    Burke JT; Wargin WA; Blum MR
    J Pharm Sci; 1980 Aug; 69(8):909-12. PubMed ID: 7400935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous chloramphenicol sodium succinate in adult patients with normal renal and hepatic function.
    Burke JT; Wargin WA; Sherertz RJ; Sanders KL; Blum MR; Sarubbi FA
    J Pharmacokinet Biopharm; 1982 Dec; 10(6):601-14. PubMed ID: 7182457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hemodialysis on total body clearance of chloramphenicol.
    Slaughter RL; Cerra FB; Koup JR
    Am J Hosp Pharm; 1980 Aug; 37(8):1083-6. PubMed ID: 7405936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of chloramphenicol therapy in the newborn infant.
    Rajchgot P; Prober CG; Soldin S; Golas C; Good F; Harding E; MacLeod S
    J Pediatr; 1982 Dec; 101(6):1018-21. PubMed ID: 7143156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal elimination kinetics of tetroxoprim and sulfadiazine in patients with renal insufficiency].
    Vergin H; Reutter FW; Sieber R; Ferber H
    Arzneimittelforschung; 1980; 30(2):313-7. PubMed ID: 7378111
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma concentrations of chloramphenicol in birds.
    Clark CH; Thomas JE; Milton JL; Goolsby WD
    Am J Vet Res; 1982 Jul; 43(7):1249-53. PubMed ID: 7103207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefadroxil kinetics in patients with impaired renal function.
    Cutler R
    J Int Med Res; 1980; 8(Suppl 1):17-20. PubMed ID: 7439499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.